Atlas Trials

Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

Clinical trial NCT01900899 · COMPLETED

Trial details

NCT number
NCT01900899
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Infections, Meningococcal
Start date
2013-07-01
Primary completion
2017-11-01
Enrollment
184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.